EPSO publishes a first reaction to the Court of Justice of the EU ruling regarding mutagenesis and the GMO Directive in which European Plant Scientists express their disappointment on the ruling which classifies plants obtained by recent techniques such as CRISPR-Cas9-mediated genome editing as GMO that are subject to extensive pre-market risk evaluations. It is contrary to scientific evidence and as it stands now, it very likely will prevent the use in Europe of such technologies to address food and nutritional security and a more positive impact of agriculture on the environment. EPSO offers to collaborate with policy makers to develop an appropriate regulation addressing the issue of how a product of NBTs differs from those achieved with other breeding approaches to balance potential benefits and risks. See brief statements from EPSO members and partners on the ECJ ruling regarding mutagenesis and GMO Directive.
- Register now for the EPSO–CINEA webinar on the LIFE programme on 12.09.2022 19/08/2022
- 2nd call Biodiversa+, the biodiversity partnership, on “Improved transnational monitoring of biodiversity and ecosystem change for science and society” will open on 8.9.2022 – Register for the info session on 20.09.2022. 17/08/2022
- Register for the 15th EPSO Plant Science Seminar – the 15th September 2022 seminar will focus on “Data Science for Understanding Plants” 16/08/2022